German diagnostics company Protagen said this week that it has received a Japanese patent for a method of identifying and selecting clones based on its UNIclone technology platform.

The UNIclone platform, which Protagen has licensed from Berlin's Max-Planck Institute, consists of libraries of human recombinant proteins representing more than 10,000 human genes. It is designed for use with the company's UNIarray companion diagnostic and UNIchip antibody profiling platform.

The company also possesses a European patent for the technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.